Test Could Help Heart Failure Therapies
Posted on: Monday, 4 June 2007, 09:00 CDT
A simple exercise test may help predict mortality risk in patients with heart failure and help doctors tailor therapies, found a U.S. study.
Researchers at Wake Forest University Baptist Medical Center evaluated a test that measures the lungs' efficiency at consuming oxygen and expiring carbon dioxide. The test has been shown to predict future hospitalizations in patients with systolic heart failure, a type in which the left chamber of the heart is too weakened to pump blood efficiently, according to Dr. Dalane Kitzman, a professor of cardiology and senior researcher on the project.
This may allow doctors to better assess patient risk, and could help them determine the most appropriate plan of care based on the prognosis of the patient, Kitzman said in a statement.
The study, published in the Journal of Cardiac Failure, studied 147 patients with congestive heart failure and found patients with systolic heart failure had a mean score of 37, which suggests an increased risk of mortality. Patients with diastolic heart failure had a mean score of 34, suggesting lower risk. The group of healthy older adults had a mean score of 32.
Source: United Press International
Related Articles
- American Heart Association Late-Breaking Clinical Trial Report: Tailoring Drug Dose to Heart Failure Patients' Response More Effective
- American Heart Association Late Breaking Clinical Trial Report: High Dose of Angiotensin Receptor Blockers Effective in Heart Failure Patients
- Study Data Show Positive European Experience With DuraHeart Left Ventricular Assist Device for Advanced Stage Heart Failure Patients
- Clinical Data Show CVRx(R) Rheos(R) Therapy Improved Heart Structure and Function in Early-Stage Heart Failure Patients
- Heart Failure Patients Aided By Nurse Care
- St. Jude Medical Announces Japanese Approval of CRT-D Products to Treat Heart Failure Patients
- Vanderbilt Enrolling Heart Failure Patients in New Pacing Device Study
- Medications Keep Heart-Failure Patients Alive
- Data From Two Published Studies Show Short- and Long- Term Benefits of CHF Solutions' Aquapheresis(TM) Therapy in Treating Heart Failure Patients With Fluid Overload
- Role of Cholesterol Lowering Drugs in Heart Failure Patients Evaluated in Yale Medical Center's Heart Study
User Comments (0)

RSS Feeds